Podcast: Abstract: Background: Kidney transplant (KT) recipients experience high rates of cardiovascular disease, allograft dysfunction, and diabetes, negatively impacting long-term outcomes
therefore, patients and health care providers are often searching for additional strategies to promote weight loss, and certainly strategies to avoid or attenuate weight gain
Increase mitochondrial energy production Your mitochondria are responsible for producing cellular energy
But the cat is out of the bag for these new GLP-1 drugs
If weight management is a goal, note that Wegovy (not Ozempic) is the licensed semaglutide product for this purpose in the UK
Method selection should be driven by the required conjugation site, substrate electrophilicity, oxidation sensitivity, and whether the customer needs a metabolite-like adduct, a preserved free-thiol derivative, or a labeled construct for downstream assay use